Intercellular interactions within the branchial arch (BA) system is essential for craniofacial development. Endothelin-1 (ET-1), produced by the branchial epithelium and core mesenchyme, acts on cranial neural crest-derived ectomesenchymcal cells expressing endothelin A receptor (ETAR) and regulates expression of crucial genes such as Dlx6, a member of distalless homeobox gene family, and its downstream target dHAND, a basic helix-loop-helix transcription factor. To investigate the role of ET-1 and subsequent signaling cascades in BA development, we examined when and how they activate dHAND and Dlx6 expression. ETAR blockade by BQ123 in mouse embryo culture has revealed that ET-1/ETAR signaling is critical for dHAND and Dlx6 expression in the mandibular arch mesenchyme around embryonic day (E)8.75-E9.0 and becomes dispensable by E9.5. dHAND and Dlx6 expression after E9.5 was dependent on the presence of the epithelium, which was partly mediated by FGF-like signals. These findings indicate that ET-1/ETAR and subsequent epithelial signals are sequentially involved in BA development by maintaining dHAND and Dlx6 expression. Furthermore, discordance of dHAND and Dlx6 expression domains and heterogeneity with respect to dependency on ET-1 and FGF-like signals suggest that genetic hierarchy involving Dlx6 and dHAND is differently controlled among subdomains within the mandibular arch. q
Introduction
The branchial arch (BA) system is a transient segmental structure that is conserved in all vertebrates and mainly contributes to craniofacial development during embryogenesis (Noden, 1998; Depew et al., 2002a) . The first BA (BA1) gives rise to the lower jaw and part of the upper jaw, as well as to the lateral part of the skull and some of the components of the middle ear. In mouse embryos, BA1 first becomes visible around embryonic day (E) 9.0, just as the cranial neural crest cells migrate into and condense within the arch. This neural crest-derived mesenchyme, termed ectomesenchyme, interacts with epithelial and mesodermal cell populations within the arch and differentiates into cartilagenous (chondrocranial) and osseous (dermatocranial) structures (Noden, 1998; Köntges and Lumsden, 1996; Le Douarin and Kalcheim, 1999) . The outgrowing BA1 develops into the mandibular and maxillary arches, which in turn contribute to the formation of the lower and upper jaws, respectively.
Positional identities within BA1 are known to correlate with the cell type-specific expression of certain transcriptional factor genes (Graham, 2002; Depew et al., 2002a) .
In particular, the Dlx genes, vertebrate distalless homologues, are differentially expressed along the dorsoventral axis in BA1 (Qiu et al., 1997; Depew et al., 1999) . Dlx1 and Dlx2 are expressed in both the maxillary (dorsal) and the mandibular (ventral) components of BA1, whereas the expression of Dlx3, Dlx5 and Dlx6 are restricted to the mandibular component of BA1. Inactivation of Dlx5 and Dlx6 in mice resulted in a homeotic-like transformation of the lower jaws to upper jaws (Depew et al., 2002b; Beverdam et al., 2002) , suggesting an essential role for Dlx5/6 in the determination of mandibular arch identity.
The endothelins (ET-1, -2 and -3) are a peptide family that exert a variety of biological effects including vasoconstriction and cell proliferation via the G protein-coupled endothelin receptors type A and B (ETAR and ETBR, respectively) (Kurihara et al., 1999; Kedzierski and Yanagisawa, 2001 ). Gene targeting experiments have shown that ET-1/ETAR signaling is necessary for the development of cranial neural crest-derived structures including BA1 (Kurihara et al., 1994 (Kurihara et al., , 1995 Clouthier et al., 1998; Kempf et al., 1998; Miller et al., 2000) , whereas ET-3/ETBR signaling is necessary for the development of melanocytes and enteric nerves, derivatives of the trunk and vagal neural crest Hosoda et al., 1994) . In mouse embryos, ET-1 is expressed in the epithelium and paraxial mesoderm core of the BAs, whereas the EdnrA gene encoding ETAR is in neural crest-derived ectomesenchymal cells (Kurihara et al., 1994 (Kurihara et al., , 1995 Maemura et al., 1996; Clouthier et al., 1998) . Thus, ET-1 is assumed to act on EdnrA-expressing neural crest-derived ectomesenchyme as a mediator of the regional intercellular interactions.
Several transcription factors appear to serve as downstream targets for ET-1/ETAR signaling in BA1. For example, it has been shown that expression of dHAND and eHAND, members of the basic helix-loop-helix (bHLH) protein family, in BA mesenchyme is significantly downregulated in ET-1 2/2 or ETAR 2/2 embryos (Thomas et al., 1998; Clouthier et al., 2000) . Significantly, disruption of dHAND leads to severe craniofacial and cardiovascular abnormalities in mice (Thomas et al., 1998; Yanagisawa et al., 2003) . Dlx6 links ET-1/ETAR signaling and dHAND expression by acting directly on the BA-specific dHAND promoter (Charité et al., 2001) . Recently, we have found that the phenotype of the ET-1 2/2 mutant mice can be interpreted as a homeotic-like transformation of the lower jaw to an upper jaw (Ozeki et al., 2004) . Correspondingly, the expression of Dlx5, Dlx6 and other mandibular marker gene such as Pitx1 is significantly downregulated in the ET-1 2/2 mutant (Ozeki et al., 2004) . These findings indicate that ET-1/ETAR signaling to activateDlx5 and Dlx6 expression is crucial for the dorsoventral axis patterning of the BA system.
To further understand the molecular mechanism underlying the signaling cascade involving ET-1/ETAR in BA development, we examined the temporal requirement of the ET-1/ETAR and subsequent signals driving BA development. Here, we demonstrate that ET-1/ETAR signaling around E8.75 -E9.0 is critical for the mandibular expression of dHAND and Dlx6 and that the signaling relay from ET-1/ETAR to subsequent epithelial signals including FGF-like signals is essential for dHAND and Dlx6 expression thereafter. The requirement for ET-1 and FGFlike signals is different among subdomains within the mandibular arch, suggesting that different signaling cascades regulate dHAND and Dlx6 expression.
Results

Pharmacological inactivation of ET-1/ETAR signaling in whole-embryo cultures
We first evaluated the effect of ET receptor antagonists on the expression of dHAND in mouse whole-embryo culture. Treatment of embryos excised at E8.5 with 10 mM BQ123, an ETAR-specific antagonist (Ihara et al., 1992) , markedly downregulated dHAND expression in the mandibular arch mesenchyme as seen in ET-1 2/2 embryos (Fig. 1A,B,D) . This treatment did not inhibit dHAND expression in the limb buds (Fig. 1A,B) , whose expression is independent of ET-1/ETAR signaling (Thomas et al., 1998) . In contrast, BQ788, a specific ETBR antagonist (Ishikawa et al., 1994) , had no effect on dHAND expression (Fig. 1C) .
We next examined the effect of BQ123 on the expression of the Dlx gene family. Treatment of embryos excised at E8.5 with BQ123 resulted in marked down-regulation of the expression of Dlx3 (Fig. 3C,D) , Dlx5 (Fig. 3E,F) and Dlx6 ( Fig. 2A,B) in the mandibular arches, whereas Dlx2 expression was not largely affected (Fig. 3A,B) . These expression patterns of the Dlx genes in BQ123-treated embryos are similar to those in ET-1 2/2 or Ednra 2/2 embryos (Clouthier et al., 2000; Ozeki et al., 2004) . Thus, the pharmacological blockade of ETAR by BQ123 can reproduce the phenotype of ET-1 2/2 and Ednra 2/2 embryos in culture.
Temporal requirement of ET-1/ETAR signaling for dHAND expression
We then used this pharmacological blockade to determine the temporal requirement of ET-1/ETAR signaling during BA development. For this purpose, we treated mouse embryos with BQ123 for various periods and examined its effect on dHAND expression. When embryos excised at E8.5 or E8.75 were cultured in the presence of BQ123, dHAND expression was down-regulated as seen in ET-1 2/2 embryos (Fig. 1B,E) . On the other hand, treatment of embryos excised at E9.0 with BQ123 resulted in a partial downregulation of dHAND expression (Fig. 1F ). BQ123 treatment from E9.5 or later did not affect dHAND expression (Fig. 1G,H) . Culturing mandible explants after 48 h whole embryo culture in the presence or absence of BQ123 did not alter in situ results seen in whole embryo culture alone (data not shown). These results indicate that the ET-1/ETAR signaling during the period around E8.75 -E9.0 is essential for dHAND expression in the mandibular arch mesenchyme but it becomes dispensable by E9.5.
Temporal requirement of ET-1/ETAR signaling for Dlx6 expression
We also determined the temporal requirement of ET-1/ETAR signaling for the expression of Dlx6, which is known to mediate ET-1/ETAR-dependent dHAND expression by acting directly on the dHAND promoter (Charité et al., 2001) . When embryos excised at E8.5 or E8.75 were cultured in the presence of BQ123, Dlx6 expression was also down-regulated ( Fig. 2A -C) . When embryos were excised at E8.75 and BQ123 was added to culture medium 12 h later, Dlx6 expression was only partially inhibited (Fig. 2D ). BQ123 treatment from E9.5 or later did not affect Dlx6 expression (Fig. 2E,F) . Thus, the temporal requirement of ET-1/ETAR signaling for Dlx6 expression in the mandibular arch parallels that for dHAND expression, although the spatial pattern of Dlx6 expression at E10.5 only partially overlapped with that of dHAND in the venterolateral region of the mandibular arch (Figs. 1A and 2A).
Sequential requirement of ET-1 and other epithelial signals for dHAND and Dlx6 expression
We next examined whether dHAND and Dlx6 expression in the mandibular arch was maintained autonomously or was affected by local factors other than ET-1 after E9.5. To address this question, we cultured mandibular arch explants harvested at E10.5 with or Fig. 1 . Pharmacological inactivation of ET-1/ETAR-mediated signaling in cultured mouse embryos. E8.5 mouse embryos were cultured for 48 h with vehicle (A), 10 mM BQ123 (B) or 10 mM BQ788 (C), and were probed for expression of dHAND. E10.5 ET-1 2/2 embryos were also subjected to whole-mount in situ hybridization (D). (E)-(H) Time-dependent effects of ETAR blockade on dHAND expression in mandibular arches. E8.75 (E) and E9.0 (F)-(H) embryos were subjected to whole-embryo culture (WEC) for 42 h (E) or 36 h (F)-(H). BQ123 was added to the culture medium when the embryos had developed to E8.75 (E), E9.0 (F), E9.5 (G) or E10.0 (H). The time course of WEC is illustrated in the diagram. Whole-mount in situ hybridization was performed on cultured embryos using a dHAND antisense probe: upper, frontal views of BAs; middle, rostral views of BA1; lower, forelimb buds (arrows). Pictures are representative of at least four independent experiments containing at least four samples for each condition.
without epithelium and examined dHAND expression. Removal of the epithelium resulted in a loss of the mesenchymal dHAND expression (Fig. 4B,C) , suggesting that some epithelial signals may be required for the maintenance of dHAND expression. This is confirmed by recombination experiments, in which the replacement of epithelium could sustain dHAND expression in the denuded mesenchyme (Fig. 4D ).
To further investigate the relationship between the precedent ET-1/ETAR signaling and subsequent epithelial Fig. 2 . Time-dependent effects of ETAR blockade on Dlx6 expression in mandibular arches. As shown in the diagram, E8.5 (A), (B), E8.75 (C), (D) and E9.5 (E), (F) mouse embryos were subjected to whole embryo culture (WEC) for 48 (A), (B), 42 (C), (D) or 24 h (E), (F). BQ123 was added to the culture medium when the embryos had developed to E8.5 (B), E8.75 (C), E9.25 (D), E9.5 (E) or E10.0 (F). Whole-mount in situ hybridization was performed on cultured embryos using a Dlx6 antisense probe: upper, frontal views of BAs; lower, rostral views of BA1. Pictures are representative of three independent experiments containing at least four samples for each condition. Fig. 3 . Effects of ETAR blockade on the expression of Dlx2, Dlx3 and Dlx5 in mandibular arches. E8.5 mouse embryos were subjected to whole embryo culture without (A), (C), (E) or with (B), (D), (F) 10 mM BQ123 for 48 h. Whole-mount in situ hybridization was performed on cultured embryos using antisense probes for Dlx2 (A), (B), Dlx3 (C), (D) and Dlx5 (E), (F): upper, frontal views of BAs; lower, rostral views of BA1. Pictures are representative of three independent experiments containing at least four samples for each condition.
signaling, we swapped the epithelium between wild-type and ET-1 2/2 mandibular explants and examined dHAND expression. When epithelium derived from E10.5 ET-1 2/2 embryos was recombined with denuded wild-type mandibular mesenchyme, mesenchymal dHAND expression was sustained (Fig. 4E) . Conversely, recombination of wild-type epithelium with ET-1 2/2 mandibular mesenchyme did not upregulate dHAND expression, although only a trace of dHAND expression, which may be of wild-type mesenchyme carried with the recombined epithelium, was detected (Fig. 4F) .
Similar recombination experiments were performed for Dlx6 expression. Again, Dlx6 expression in the mandibular arch was greatly decreased by removal of the epithelium and restored by recombining the epithelium with the denuded mesenchyme ( Fig. 4G -I ). Recombining the mandibular arch epithelium from ET-1 2/2 embryos with wild-type denuded mesenchyme also sustained Dlx6 expression (Fig. 4J) , whereas wild-type epethelium did not upregulate Dlx6 expression in ET-1 2/2 mesenchyme (Fig. 4K) .
Possible involvement of FGF-like signaling in the epithelium-dependent expression of dHAND and Dlx6
Several signaling molecules, including FGFs, BMPs, Shh and Wnts, are known to be produced in the branchial region and to be involved in craniofacial morphogenesis (FrancisWest et al., 1998; Depew et al., 2002a) . Among these factors, we found that FGF8 could significantly affect dHAND and Dlx6 expression. When BSA-and FGF8-soaked beads were placed on the midline of denuded wildtype mandibular mesenchyme, dHAND expression was detected only around FGF beads (Fig. 5A,B) . When FGF8 beads were placed on more lateral surface, dHAND expression was up-regulated in the medial region of denuded mesenchyme corresponding to its own expression domain (Fig. 5C ). FGF8 beads could also upregulate Dlx6 expression in its own expression domain in denuded mesenchyme (Fig. 5D ). By contrast, mandibular mesenchyme derived from ET-1 2/2 embryos expressed neither dHAND nor Dlx6 in response to FGF8, whereas dHAND expression in the midline region and Dlx6 expression in the lateral region, which are independent of ET-1/ETAR signaling (Clouthier et al., 2000; Yanagisawa et al., 2003; Ozeki et al., 2004) , were observed (Fig. 5E,F) . In BQ123-pretreated mandibular mesenchyme, Dlx2 expression was upregulated by FGF8, although Dlx6 expression was not (Fig. 5G,H) , suggesting that responsiveness of mesenchyme to FGF signaling is preserved in the absence of precedent ET-1/ETAR signaling.
These results suggest the involvement of FGF-like signaling in the epithelium-dependent maintenance of dHAND and Dlx6 expression. To confirm this possibility, we tested the effect of 50 mM SU5402, a specific FGF receptor antagonist, on dHAND and Dlx6 expression in mandibular arch explants. When mandibular explants were excised from E10.5 embryos and were cultured for 24 h in the presence of SU5402, aboral dHAND expression was lost but the oral expression remained intact (Fig. 6A,B) . The same result was reproduced when mandibular explants were excised from E9.5 embryos and were cultured for 48 h in the presence of SU5402 (Fig. 6C,D) . Dlx6 expression in the mandibular arch was also down-regulated by SU5402 except for the lateral region, where Dlx6 expression is preserved in E10.5 ET-1 2/2 embryos (Ozeki et al., 2004) (Fig. 6E,F) . These results suggest that the epithelial signals responsible for the maintenance of mandibular dHAND and Dlx6 expression involves, at least in part, FGF-like signals but FGF dependency appears to be different among subdomains within the mandibular arch.
Finally, we examined whether FGF-like signals were necessary for ET-1/ETAR-dependent gene expression before E9.5. Treatment of embryos before E9.5 with SU5402, however, did not largely affect Dlx6 expression in the mandibular arch (Fig. 7) , indicating that FGF-like signaling is dispensable for Dlx6 expression before E9.5.
Discussion
ET-1/ETAR and subsequent epithelial signals are sequentially involved in mandibular Dlx6 and dHAND expression
Inter-BA and intra-BA identities are established through a regional balance of signaling interactions among different cell components. Recent findings demonstrate that the induction of Dlx5 and Dlx6 expression in the ventral region within BA1 is critical for determination of the mandibular identity (Depew et al., 2002b; Beverdam et al., 2002) . Dlx5 and Dlx6 expression is downregulated in ET-1 2/2 and ETAR 2/2 embryos, whose mandibular morphology resembles that of Dlx5/Dlx6 double mutant mice (Clouthier et al., 2000; Ozeki et al., 2004) , indicating that ET-1/ETAR signaling is essential for the dorsoventral axis patterning of BA1 through Dlx5 and Dlx6 induction.
In the present study, we applied pharmacological inactivation to mouse whole-embryo culture to mimic the phenotype of ET-1 2/2 embryos. Treatment of embryos excised at E8.5 with an ETAR antagonist BQ123 downregulated Dlx3, Dlx5 and Dlx6 expression in the mandibular arch as seen in ET-1 2/2 embryos (Ozeki et al., 2004) . In contrast, Dlx2 expression was not affected, suggesting that cranial neural crest cells migrated into the mandibular arch to form ectomesenchyme but failed to express mandibular arch-specific genes. Further temporal analysis by BQ123 revealed that ET-1/ETAR signaling is critical for dHAND and Dlx6 expression in the mandibular arch mesenchyme during the period around E8.75 -E9.0 and becomes dispensable by E9.5. Previously, most of the teratogenic effects of an ETAR antagonist in rats have been shown to occur around E10.0, the stage of 5 -12 somites in this animal (Spence et al., 1999) . These findings together indicate that ET-1/ETAR signaling is directly involved in the induction of genes critical for determination of the mandibular identity within BA1 before E9.5 in mice.
The present study has also shown that Dlx6 and dHAND expression after E9.5 depends on the presence of the epithelium. ET-1 does not mediate this interaction because BQ123 did not inhibit it and ET-1 2/2 epithelium could maintain Dlx6 and dHAND expression in denuded wild-type mesenchyme. In contrast, mandibular mesenchyme from ET-1 2/2 embryos did not respond to wild-type epithelium, suggesting that the mesenchyme must be primed by precedent ET-1/ETAR signaling to respond to subsequent epithelium-derived signals. Experiments using FGF8-soaked beads and an FGF receptor antagonist SU5402 demonstrate that FGF-like signaling is partly involved in this epithelial-mesenchymal interaction.
Among FGF family members, FGF8 has been implicated in BA development, as deletion of FGF8 within BA1 results in the loss of structures derived from the first arch (Trumpp et al., 1999) . However, dHAND expression in mandibular arch mesenchyme is retained in FGF8-deficient mice (Abu-Issa et al., 2002) , suggesting that other FGF family members might also be involved in the epitheliumdependent Dlx6 and dHAND expression. In this regard, FGF4 and FGF9 are also expressed in the BA epithelium (Mina et al., 2002) , although there is little evidence for their involvement in BA development. In addition, FGF8 has been shown to act as a positive regulator of ET-1 expression in the BA epithelium (Trumpp et al., 1999) , suggesting the presence of a complex regulatory loop between the ET-1 and FGF signaling pathways.
How does ET-1/ETAR signaling prepare BA1 cells for subsequent epithelium-dependent maintenance of Dlx6 and dHAND expression? One possible explanation may be that ET-1/ETAR signal induces expression or activation of FGF receptors and/or related intracellular signaling molecules responsible for mandibular Dlx6 and dHAND expression. However, Dlx2 expression in mandibular arch mesenchyme, which is also thought to be regulated by FGF signaling (Ferguson et al., 2000; Abu-Issa et al., 2002) , is unchanged in ET-1 2/2 and ETAR 2/2 embryos (Clouthier et al., 1998; Ozeki et al., 2004) , and placement of FGF8 beads on mesenchyme treated with BQ123 induced Dlx2 expression. This means that FGF receptor(s) and/or the intracellular signaling molecules regulating Dlx6/dHAND and Dlx2 expression in mandibular arch mesenchyme may be different in terms of the dependency on ET-1/ETAR signaling. Another explanation may be that FGF-dependent maintenance of Dlx6 and dHAND expression requires ET-1-induced changes in promoter activity in advance. Further investigation should clarify the mechanism underlying the signaling relay from the precedent ET-1/ETAR to FGF-like signals in maintaining Dlx6 and dHAND expression.
Heterogeneity within the mandibular arch with respect to the regulation of Dlx6 and dHAND expression
Dlx6 has been shown to act as a transducer of ET-1/ETAR signaling to activate dHAND expression through its BA-specific enhancer (Charité et al., 2001) . However, Dlx6 and dHAND expression is only partially co-localized in the branchial arch. Consistently, heterogeneity within the mandibular arch with respect to cis-regulatory elements driving dHAND transcription has recently been reported (Yanagisawa et al., 2003) . In addition, responsiveness to SU5402 was also different within dHAND expression domain.
Taking these findings together, the mandibular arch might be divided into 4 subdomains (Fig. 8) . In subdomain A, Dlx6 and dHAND expression is co-localized and appears to depend on ET-1/ETAR signaling. This subdomain may correspond to the domain previously defined as dependent on Dlx6 controlled by the BA-specific enhancer (Yanagisawa et al., 2003) . dHAND expression in this domain is resistant to SU5402, although Dlx6 is sensitive to it. Dlx6 may not be required for the maintenance of dHAND expression once it is induced. In subdomain B, dHAND expression is dependent on ET-1/ETAR and subsequent FGF-like signaling. Because this region lacks Dlx6 expression, other transcription factor(s) may mediate ET-1/ETAR-dependent dHAND expression. In subdomain C, dHAND expression is independent of ET-1/ETAR (typically shown in Fig. 5E ). dHAND expression in this region as well as subdomain A is resistant to SU5402, but depends on the presence of the epithelium, suggesting the requirement for other epithelial signals. In subdomain D, dHAND expression is absent although Dlx6 is expressed. dHAND expression was not definitely upregulated by FGF8 beads in this region, although Dlx6 and Dlx2 were upregulated. The lack of dHAND expression in this subdomain may be explained by the presence of transcriptional repression as previously suggested (Charité et al., 2001) . It is also noteworthy that Dlx6 expression in the lateral portion of this subdomain is independent of both ET-1 and FGF-like signals, suggesting the presence of different signaling cascade regulating Dlx6 expression. Thus, genetic hierarchy involving Dlx6 and dHAND appears to be differently controlled among subdomains within the mandibular arch and the direct link between ET-1/ETAR, Dlx6 and dHAND (Charité et al., 2001 ) is restricted to subdomain A. How this heterogeneity may contribute to the morphogenesis of each structural component within the mandibular arch is an issue to be further investigated.
Materials and methods
Animals
ICR mice were purchased from CLEA Japan. Mouse strains harboring the ET-1 null mutation were established by gene targeting, as previously described (Kurihara et al., 1994) , and were maintained on the ICR background. Pregnant mice were killed by cervical dislocation and embryos were dissected from the uterine decidua. The point at which the vaginal plug appeared was considered to be E0.5. Exact embryonic stages were confirmed using morphological criteria (http://www.genex.hgu.mrc.ac.uk/ Databases/Anatomy/MAstaging.shtml). All experiments were performed under the guidelines of Kumamoto University and The University of Tokyo for animal and recombinant DNA experiments.
Mouse whole-embryo culture
E8.5 -E9.5 embryos were carefully dissected from the uterus under an optical microscope, making sure the placenta and embryonic membranes remained intact, and cultured as described elsewhere (Osumi and Inoue, 2001 ). Briefly, 3 or 4 embryos were placed in a 15 ml culture bottle containing 2.5 ml of culture medium composed of 100% rat serum with 2 mg/ml glucose. For embryos treated with BQ123 (Calbiochem) or BQ788 (Calbiochem), the respective antagonist was added to the culture medium to a final concentration of 10 mM. The culture bottles were incubated at 37 8C and rotated at 20 rpm while being continuously supplied with a suitable concentration of O 2 (5, 20 or 60%) and CO 2 (5%) balanced with N 2 .
Explant cultures
Mandibular arches were dissected from E10.5 -E11.5 embryos in phosphate buffered-saline (PBS) under an optical microscope. To remove the epithelium from the mesenchyme, explants were incubated for 10 min at 37 8C with dispase (2 units/ml) made up in Ca 2þ -and Mg 2þ -free PBS and then washed with BGJb medium (Gibco-BRL) supplemented with 10% fetal bovine serum, 50 U/ml penicillin/streptomycin and 0.1 mg/ml ascorbic acid. Thereafter, the tissues were mechanically separated using fine tungsten needles. In recombination experiments, the midline of the mandibular mesenchyme was overlaid with the epithelial tissue ( Fig. 2A ). Mandibular explants with or without the epithelium were placed oral (rostral) side up on Millipore membrane filters (0.8 mm pore size) supported by metal grids according to the modified Trowel technique (Trowel, 1959) . They were then cultured in BGJb medium at 37 8C in a humidified atmosphere of 95% air and 5% CO 2 . In some experiments, beads prepared as described below were placed on top of the mesenchyme.
For preparation of FGF8b beads, heparin acrylic beads (Sigma) were washed five times in PBS and then incubated overnight at 4 8C in 1 mg/ml FGF-8b (R&D Systems). The beads were then stored for up to 2 weeks at 4 8C.
In situ hybridization
Embryos and organ culture samples were fixed in 4% paraformaldehyde in PBS and then subjected to wholemount digoxigenin in situ hybridization, which was carried out as described by Wilkinson (1992) . Riboprobes for dHAND were prepared as previously described (Thomas et al., 1998; Wright et al., 1995) ; those for Dlx2, Dlx3, Dlx5 and Dlx6 were prepared from plasmids containing each cDNA fragment obtained by RT-PCR.
